AIG
ABMD

American International Group’s Abiomed Inc ABMD Stock Holding History

American International Group’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-12,875
Closed -$3.16M – 3030
2022
Q3 		$3.16M Sell
12,875
-329
-2% -$88.8K 0.02% 831
2022
Q2 		$3.27M Sell
13,204
-1,249
-9% -$337K 0.02% 839
2022
Q1 		$4.79M Sell
14,453
-359
-2% -$111K 0.03% 801
2021
Q4 		$5.32M Sell
14,812
-152
-1% -$51.4K 0.03% 785
2021
Q3 		$4.87M Sell
14,964
-217
-1% -$73.5K 0.03% 793
2021
Q2 		$4.74K Sell
15,181
-469
-3% -$144K 0.02% 859
2021
Q1 		$4.99K Sell
15,650
-542
-3% -$173K 0.02% 826
2020
Q4 		$5.25K Sell
16,192
-67
-0.4% -$18.5K 0.02% 765
2020
Q3 		$4.5M Sell
16,259
-630
-4% -$181K 0.02% 703
2020
Q2 		$4.08M Buy
16,889
+205
+1% +$41.2K 0.02% 740
2020
Q1 		$2.42M Sell
16,684
-7
-0% -$1.16K 0.01% 823
2019
Q4 		$2.85M Buy
16,691
+403
+2% +$74.7K 0.01% 904
2019
Q3 		$2.9M Sell
16,288
-31
-0.2% -$6.7K 0.01% 887
2019
Q2 		$4.25M Sell
16,319
-592
-4% -$157K 0.02% 787
2019
Q1 		$4.83M Sell
16,911
-143
-0.8% -$47.5K 0.02% 750
2018
Q4 		$5.54M Buy
17,054
+1,256
+8% +$436K 0.02% 638
2018
Q3 		$7.11M Buy
15,798
+1,727
+12% +$681K 0.02% 631
2018
Q2 		$5.76M Sell
14,071
-70,136
-83% -$25.4M 0.02% 701
2018
Q1 		$24.5M Sell
84,207
-2,799
-3% -$709K 0.09% 108
2017
Q4 		$16.3M Sell
87,006
-4,014
-4% -$749K 0.05% 193
2017
Q3 		$15.3M Buy
91,020
+7,591
+9% +$1.15M 0.05% 188
2017
Q2 		$12M Buy
83,429
+2,668
+3% +$359K 0.04% 276
2017
Q1 		$10.1M Buy
80,761
+3,175
+4% +$368K 0.04% 371
2016
Q4 		$8.74M Buy
77,586
+563
+0.7% +$65.2K 0.03% 407
2016
Q3 		$9.9M Buy
77,023
+1,190
+2% +$143K 0.04% 316
2016
Q2 		$8.29M Sell
75,833
-24,581
-24% -$2.45M 0.03% 402
2016
Q1 		$9.52M Buy
100,414
+67,588
+206% +$5.71M 0.04% 378
2015
Q4 		$2.96M Buy
32,826
+2,230
+7% +$189K 0.01% 964
2015
Q3 		$2.84M Buy
30,596
+1,555
+5% +$137K 0.01% 959
2015
Q2 		$1.91M Sell
29,041
-596
-2% -$39.6K 0.01% 1174
2015
Q1 		$2.12M Buy
29,637
+242
+0.8% +$13.1K 0.01% 1139
2014
Q4 		$1.12M Sell
29,395
-859
-3% -$27.1K ﹤0.01% 1479
2014
Q3 		$751K Buy
30,254
+249
+0.8% +$6.31K ﹤0.01% 1783
2014
Q2 		$754K Buy
30,005
+84
+0.3% +$1.96K ﹤0.01% 1816
2014
Q1 		$779K Buy
29,921
+827
+3% +$22.9K ﹤0.01% 1745
2013
Q4 		$778K Buy
29,094
+136
+0.5% +$3.36K ﹤0.01% 1674
2013
Q3 		$552K Buy
28,958
+2,921
+11% +$66.8K ﹤0.01% 1886
2013
Q2 		$561K Buy
+26,037
New +$523K ﹤0.01% 1766

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

American International Group's ABMD Position: Q4 2022 in Review

American International Group sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 12,875 shares — an estimated $3.16M sold.

American International Group first reported a position in ABMD in Q2 2013 and held it in 38 quarters. The position peaked at $24.5M in Q1 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • American International Group reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • American International Group sold 12,875 Abiomed Inc shares in Q4 2022, an estimated $3.16M.
  • American International Group first reported a position in Abiomed Inc in Q2 2013 and held it in 38 quarters.
  • American International Group's Abiomed Inc position peaked at $24.5M in Q1 2018.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on American International Group's 13F filing for Q4 2022, filed 10 Feb 2023.